The restraint of the immune response achieved in the CNS through the anti-TNFSF10 treatment was paralleled by a significant decrease in several pro-inflammatory cytokines in the brain of anti-TNFSF10 treated 3xTg-AD mice. The gene discussed is TNFSF10; the disease is Alzheimer disease.